OOIR: Observatory of International Research

Papers

(The TQCC of Blood Coagulation & Fibrinolysis is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Lupus anticoagulant activity and thrombosis post COVID-19 vaccination	23
Bleeding risk in hemophilia A and B carriers: comparison of factor levels determined using chronometric and chromogenic assays	14
Coexpression of factor VIII and factor von Willebrand variants in a woman with heavy menstrual bleeding	14
Poisoning by butylated hydroxytoluene quinone methide acting as a superwarfarin: first reported case in humans	12
Interleukin-10 levels and the risk of thromboembolism according to COMPASS-Cancer associated thrombosis score in breast cancer patients prior to undergoing doxorubicin-based chemotherapy	12
An atypical presentation of catastrophic antiphospholipid syndrome with refractoriness to treatment	12
Comparing fondaparinux and low molecular weight heparin for thromboprophylaxis after hip and knee arthroplasty: a systematic review and meta-analysis	11
Current epidemiology of deaths for disseminated intravascular coagulation	11
Exploring the antioxidant and antithrombotic potential of Tetraclinis articulata: an in-vitro investigation on human blood	10
Predictive value of miR-24-3p and miR-1277-5p in hemodialysis patients with vascular access thrombosis	9
A study of fibrinolytic system components in donor groups depending on various titers of circulating anti-SARS-CoV-2 IgG in the bloodstream	8
Clot waveform analysis in hemophilia carriers	8
Isolated hematuria with ureterolithiasis in an infant with late-onset vitamin K deficiency bleeding	8
Obesity and physical exercise in hemophilia	8
Time-in-therapeutic range falls as the target international normalized ratio range increases in patients on warfarin	8
Characterization of thrombophilia-related plasmas evaluated by anticoagulants-mediated thrombin and plasmin generation assays	8
A multicenter, observational study to evaluate hemostasis following recombinant activated FVII treatment in patients in Japan with congenital factor VII deficiency	7
The determination of euglobulin clot lysis time reference intervals in Beckton Dickinson and Kima 3.2% sodium citrate coagulation tubes	7
Genetic and clinical characterization of factor VII deficiency: insights from 34 Turkish patients	7
Effects of cyclooxygenase and P2Y12 ADP receptor inhibitors on platelet phosphatidylserine exposure in vitro and in vivo	7
Pulmonary vein stump thrombosis after lung resection for lung cancer: clinical features and outcome	7
Glanzmann's thrombasthenia associated with gastrointestinal angiodysplasias successfully treated with bevacizumab	6
Safety of Sinopharm vaccine in patients with congenital bleeding disorders under on-demand therapy: a preliminary report	6
Efficacy of adjusted weight-based dosing of desmopressin (1-deamino-8-d-arginine vasopressin in type 1 von Willebrand disease	6
Direct oral anticoagulant adsorption and laboratory detection of lupus anticoagulant	6

A single center study: the effect of in vitro lipemia on coagulation tests	6
Decrease in in vivo coagulant potential of emicizumab in a patient with hemophilia A and inhibitor complicated with infectious mononucleosis	6
Disability and the social impact of hemophilia	6
The procoagulant potential before and after surgery for endometriosis and its association with disease severity	6
Rituximab as a treatment for refractory immune thrombocytopenia during pregnancy	6
Venous thromboembolism secondary prophylaxis in elderly people (over 75 years old) with low-dose direct oral anticoagulants	5
Factor VII Padua in Iran: clinical and laboratory findings of three unrelated patients	5
Anticoagulant and antiplatelet activity of aqueous extracts of Citrus sinensis and Lippia alba: interactions and potential for the development of antithrombotics	5
To test or not to test: JAK2V617F mutation prevalence in thrombophilia profiles	5
Rare coagulation factor deficiencies: a five-year experience from a single tertiary care center in South India	5
Endotoxemia-induced protein C surge protects mice against venous thrombosis based on transient lowering of natural anticoagulants	5
Utilization and safety of off-label prothrombin complex concentrate (four-factor prothrombin complex concentrate) in a surgical population	5
Fibrinogen reflects severity and predicts outcomes in patients with sepsis and septic shock	4
Factor VIII beyond haemophilia: a hidden regulator of venous thrombosis and endothelial dysfunction	4
Acquired factor XIII deficiency is associated with mortality and is not linked to hypocalcemia	4
An alternative method to assess the long-term stability of frozen plasmas for coagulation testing	4
A novel FGG variant associated with hereditary hepatic fibrinogen storage disease from Adana	4
A novel missense variant (c.1172A>T, p.Asn391Ile) in the gamma chain of fibrinogen causing hypodysfibrinogenemia in an asymptomatic Danish family and review of adjacent variants	4
Role of tissue factor pathway inhibitor in hormone-induced venous thromboembolism	4
Is the combination of two automated rapid assays for diagnosis of heparin-induced thrombocytopenia necessary?	4
Why do patients with antiphospholipid syndrome bleed? A clinical paradox	4
Haploidentical stem cell transplantation in DOCK8 deficiency: a case report of successful outcomes	4
Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis	4
Reduced ADAMTS13 activity and high D-dimer levels are associated with thrombosis in patients with systemic lupus erythematosus	4
A novel F13A1 gene mutation (Arg208Pro) in a Chinese patient with factor XIII deficiency	4
A rare case of essential thrombocythemia with pseudo-hyperkalemia	3
Tissue factor-dependent coagulation activation in intracranial neoplasms: a comparative study	3
Association between thrombophilic gene variants and thrombosis in the Iranian population: a systematic review and meta-analysis	3
Lupus anticoagulant hypoprothrombinemia syndrome with multiple and high-titer antiphospholipid antibodies strongly interfered with coagulation assays	3
CRISPR/Cas9 mediated generation of zebrafish f9a mutant as a model for hemophilia B	3
The factor V H1327R (rs1800595) polymorphism is associated with venous thromboembolic events: a case–control study in southern Iran	3
Patients with severe coronavirus disease 2019 have high frequency of factor 5 Leiden and prothrombin gene mutations	3
Harmonizing factor assay-related testing performed in a large laboratory network	3
Two patients with protein S deficiency and cerebral venous sinus thrombosis: nonsense mutations of the PROS1 gene may account for these deficiencies	3
The use of andexanet alfa vs. 4-factor prothrombin complex concentrates in the setting of life-threatening intracranial hemorrhage	3
Avatrombopag increased platelet count in a patient with chronic immune thrombocytopenia refractory to multiple lines of treatment	3
Advances in nanotechnology for synthetic polymer hemostats: navigating precision hemostasis	3
Performance evaluation of the Sysmex CN-6000-automated coagulation analyzers for routine coagulation tests	3
Evaluation of a 4 min 4000g centrifugation protocol for routine coagulation assays	3
Congenital factor V deficiency in Taiwan: identification of a novel variant p.Tyr1813∗ and two variants specific to East Asians	3
Analysis of heparin-induced thrombocytopenia diagnostic and management strategies in individuals with inconclusive antibody optical densities	3
Severe bleeding diathesis as onset of light-chain amyloidosis: combined excessive fibrinolysis and acquired von Willebrand disease in a young patient	3
Hemolysis detection accuracy on Stago sthemO 301	3
Phenotypic variation in severe hemophilia A is related to endogenous thrombin potential and plasma levels of factor VII	2
Measuring coagulopathy in pediatric craniofacial surgery	2
Clinical and economic implications of false-positive heparin-induced thrombocytopenia immunoassays: utility of the 4T score	2
Presentation of concurrent thrombotic thrombocytopenic purpura and Graves’ disease	2
Epidemiological study about the mental state of patients after a pulmonary embolism or deep venous thrombosis event	2
A 10-year Australian experience of rare intraabdominal venous thrombosis with comparison to deep vein thrombosis and pulmonary embolism	2
Bleeding disorders in Saudi Arabia, causes and prevalence: a review	2

Disseminated intravascular coagulation in a cohort of adult acute leukemia patients: a single center experience	2
Severe thrombocytopenia associated to bevacizumab in a patient with scleroderma, gastrointestinal angiodysplasias and refractory gastrointestinal bleeding	2
Adrenal insufficiency revealing bilateral adrenal hemorrhage related to JAK2 V617F-positive essential thrombocythemia: about two cases	2
The predictive role of platelet count for bleeding in patients with hepatitis B virus and hepatitis C virus infection	2
Management of autoimmune factor XIII deficiency in a frail, elderly patient	2
Efficacy of emicizumab therapy in two adult patients with type 3 von Willebrand disease	2
Time-dependent coagulation declines in cold-stored whole blood: a paired in-vitro comparison of rotational thromboelastometry and SEER sonorheometry	2
Hemorrhagic complications in individuals with liver disease submitted to minor oral surgery	2
Evaluation of coagulation parameters and impact of transfusion on coagulation in patients with beta thalassemia major	2
Disseminated intravascular coagulation in acute leukemia patients	2
Warfarin versus direct oral anticoagulants in South Asian octogenarians: a retrospective review	2
Serum levels of inflammatory markers, sP-selectin, IL-1β, IL-6, and hsCRP are positively correlated with tissue factor transcript level of peripheral blood mononuclear cells in stroke	2
Recombinant ADAMTS13 in thrombotic thrombocytopenic purpura: a systematic review and meta-analysis	2
Effect of hyperbilirubinemia and phototherapy on apoptotic microparticle levels in neonates	2
Effects of Momordica charantia exosomes on platelet activation, adhesion, and aggregation	2
Recessively inherited protein C deficiency in two sisters: intracerebral hemorrhage and coagulopathy complications	2
Enhancing prediction of thrombosis associated with breast cancer using prechemotherapy hematologic and coagulation characteristics	2
Comment on: coagulopathy following Crotaline snakebites in northeast Florida	2
Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case–control study in Canada	2
Characterization of zebrafish coagulation cofactors Fviii and Fv mutants and modeling hemophilia A and factor V deficiency	2
Sustained good response to rituximab in acquired von Willebrand syndrome	2
Hemostatic cover in orthopedic surgery	2
Thrombin generation assay: the present and the future	2
Psychological complications among patients with congenital bleeding disorders	2
Silent progression of hemophilic arthropathy of the elbow: case reports of three pediatric patients	2
Safety and efficacy of thrombolytic interventions in the treatment of intermediate and high-risk pulmonary embolism	2
Left ventricular assist device thrombosis in the setting of supratherapeutic international normalized ratio (INR) and bleeding	2
Dihydromyricetin exhibits potent antiplatelet activity with minimal impact on coagulation system: an in vitro study	2
Interpreting coagulation mixing study results in the era of direct oral anticoagulants	2
Dysfibrinogenemia: discrepant results following infusion of purified fibrinogen	2
Molecular mechanism analysis of a family with hereditary coagulation FXI deficiency caused by compound heterozygous mutations	2
Acquired bleeding disorders secondary to immune checkpoint inhibitors: a case report and systematic literature review	2
Quantifying time from last dose: do direct oral anticoagulant assays correlate with patient's reported last dose	2